Author: Tom Wilemon
Surgeons target pancreatic cancer with electrons using new technology
Jan. 19, 2023—Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
New approach outperforms existing cancer susceptibility models
Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
Lovly receives Asclepios Award from GO2 for Lung Cancer
Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Nov. 16, 2022—Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.
Study finds inherited link to appendix cancer
Nov. 11, 2022—A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.
Study reveals pathways for aggressive prostate cancer subtype
Oct. 27, 2022—Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.
Event set to make lung cancer screening more accessible
Oct. 20, 2022—Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks
Osterman appointed chair of mCODE executive committee
Oct. 20, 2022—Vanderbilt's Travis Osterman, DO, MS, has been appointed chair of the executive committee for the Minimal Common Data Elements (mCODE) initiative.
Vanderbilt Health Pleasant View now open
Sep. 30, 2022—The new Vanderbilt Health Pleasant View outpatient clinic offers greater convenience to primary care and specialized medical services for patients in Cheatham, Montgomery and Robertson counties.
Vanderbilt lauded for pancreatic cancer, pancreatitis care
Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.
Lung cancer detection program lands grant renewal
Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.
